Skip to main content
. Author manuscript; available in PMC: 2014 Mar 10.
Published in final edited form as: Exp Cell Res. 2013 Jan 16;319(5):697–706. doi: 10.1016/j.yexcr.2012.12.026

Figure 3.

Figure 3

EGCG and SFN combination treatment can inhibit growth of ovarian cancer cells m colonogenic assays. SFN (10 µmol/L) treatment alone can significantly inhibit colony formation compared with control. EGCG (20 µmol/L) and SFN (10 µmol/L) combination treatment can significantly inhibit colony formation compared with SFN treatment alone. The inhibition effect of EGCG and SFN combination treatment or SFN alone treatment is significantly stronger in paclitaxel-resistant ovarian cancer cells (SKOV3TR-ip2) than in sensitive cells (SKOV3-ip1). * P<0.05.